Chronic Hepatitis E Virus Infection during Lymphoplasmacytic Lymphoma and Ibrutinib Treatment

Chronic Hepatitis E Virus Infection during Lymphoplasmacytic Lymphoma and Ibrutinib Treatment

Hepatitis E virus (HEV) is an increasingly recognised pathogen, affecting several hundred thousand individuals in western countries each year. Importantly, the majority of immunocompromised individuals are not able to clear HEV but develop a chronic course of infection. In the case of lymphoma, whic...

Full description

Bibliographic Details
Main Authors: Bernhard Schlevogt, Volker Kinast, Julia Reusch, Andrea Kerkhoff, Dimas Praditya, Daniel Todt, Hartmut H. Schmidt, Eike Steinmann, Patrick Behrendt
Format: Article
Language:English
Published: MDPI AG 2019-08-01
Series:Pathogens
Subjects:
hepatitis E virus
ibrutinib
Bruton’s tyrosine kinase
chronification
lymphoplasmacytic lymphoma
immunosuppression
Online Access:https://www.mdpi.com/2076-0817/8/3/129

Internet

https://www.mdpi.com/2076-0817/8/3/129

Similar Items